SCHEMBL4052839

SCHEMBL4052839

Cn1ncc2c(Nc3cccc(Cl)c3)ncnc21

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.75
LMNA P02545 3/20 0.75
MAPT P10636 7/20 0.69
MEN1 O00255 3/20 0.69
HPGD P15428 3/20 0.69
KMT2A Q03164 3/20 0.69
HSD17B10 Q99714 3/20 0.69
ALDH1A1 P00352 3/20 0.69
TP53 P04637 3/20 0.69
GAA P10253 1/20 0.69
TSHR P16473 1/20 0.69
HTT P42858 1/20 0.69
NPSR1 Q6W5P4 1/20 0.69
POLB P06746 2/20 0.68
MAPK1 P28482 2/20 0.68
CYP1A2 P05177 1/20 0.68
HSP90AA1 P07900 1/20 0.68
CYP3A4 P08684 1/20 0.68
CYP2C9 P11712 1/20 0.68
CYP2C19 P33261 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13100664 0.81 KMT2A (1.00) KDM4EMAPTMEN1HPGDKMT2A
SCHEMBL4741962 0.81 EGFR (0.58) KDM4ELMNAMAPTMEN1HPGD
SCHEMBL6265421 0.79 MAPT (1.00) KDM4ELMNAMAPTMEN1HPGD
SCHEMBL13943678 0.78 KMT2A (0.93) KDM4EMAPTMEN1HPGDKMT2A
SCHEMBL16363393 0.77 HAVCR2 (1.00) KDM4ELMNAMAPTMEN1HPGD
SCHEMBL13100621 0.76 KMT2A (0.89) KDM4ELMNAMAPTMEN1HPGD
SCHEMBL13943708 0.76 MEN1 (0.81) KDM4EMAPTMEN1HPGDKMT2A
SCHEMBL29110517 0.76 MAPT (0.57) KDM4ELMNAMAPTMEN1HPGD
SCHEMBL29771431 0.76 MAPT (0.57) KDM4ELMNAMAPTMEN1HPGD
SCHEMBL15452549 0.76 KMT2A (0.87) KDM4EMAPTMEN1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009029617-A1 DIARYLAMINE-SUBSTITUTED QUINOLONES USEFUL AS INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITORS KALYPSYS, INC. (US) 2009-03-05 WO disclosed